Assicurazioni Generali S.p.A. (G.MI): analysis and signal as of September 4, 2026

Published on September 4, 2026 at 13:13 · Updated on September 4, 2026 at 13:13 · by Aurélien Ambert, QDNA

Exchange : Euronext Milan · Sector : Finance

In short

The signal on Assicurazioni Generali S.p.A. (G.MI) remains weak with a vote of 3/3 and an indeterminate score, due to an insurance sector disadvantaged by the rate regime and a lack of verifiable fundamental data on FY 2025 and S1 2026.

Current signal: weak (vote 3/3)
Deterministic score: -2.0 → signal expected by the scale : no signal (September 10, 2026)
Layers: fundamentals : neutral, price : positive, risks : neutral

Triggered rules

Rule	Weight
penalizes an asset whose net debt/EBITDA exceeds the threshold, and the use of leverage (margin/lombard)	-2.5
moderately favors a positive 12-1 month momentum (tailwind), BUT guardrail: costly rotation, long-term reversal, momentum crashes, a conviction signal, not a rotation trigger	+0.5

Thesis

Generali ticks the defensive box with euro exposure and stable dividend, but the insurance sector is penalised at the tail of the bullish sector ranking and the ROE 13,5 % target of the Lifetime Partner 24 plan remains to be verified on FY 2025 and S1 2026. The weighted deterministic signal is negative, at -0,50, with no major technical catalyst before the BCE meeting on 10/09, and the positive technical verdict alone is not enough without live fundamental validation.

Bull case

The macroeconomic regime rated EXPANSION +0,44 remains favourable to defensive stocks, and the MM50/MM200 trend confirmation at +3,1 %/+20,2 % provides technical support. The pan-European diversification through Austria CAVIE/VIG and the CEE zone broadens the geographic exposure beyond the domestic market, while the institutional shift, intraday +32,8 % over 6 months versus overnight +6,8 %, signals medium-term accumulation by specialised participants.

Bear case

Generali does not appear in any of the four favoured sectors of the brief (semis/AI, electrification, energy, defensive healthcare), which deprives the case of the current sector tailwind. The insurance sector suffers from the BCE rate hike effect at 2,25 %, i.e. +0,25 pt over six months, which is unfavourable to long durations. The lack of verifiable live data on FY 2025, S1 2026, PER, Solvency II Tier 1 2026, M-Score and Italian BTP exposure prevents confirmation of the achievement of the 13,5 % ROE target in the current context.

Scenarios

The bullish scenario, at 35 % probability, targets 30-32 EUR on achievement of the 13,5 % ROE target and an accommodative BCE catalyst on 10/09. The central scenario, at 45 % probability, envisages a consolidation between 26 and 29 EUR with FY 2025 and S1 2026 results in line with the plan and a preserved bullish trend. The bearish scenario, at 20 % probability, contemplates 22-23 EUR, i.e. -15 % maximum decline, in the event of a miss on ROE, a BCE rate hike and tension on Italian sovereign debt.

Risks

Conviction remains weak and the absence of live fundamental data prevents any robust validation. The invalidation risk would materialise on a breakdown of the 200-session moving average at the close, given exposure to Italian sovereign debts. Sensitivity to BCE monetary policy decisions, expected on 10/09, as well as exposure to long durations, amplify volatility in a scenario of rising rates.

Signal history (last 12 months)

Date	Signal	New fact
September 4, 2026	weak (3/3)	No new quantified facts have appeared since the previous verdict, the layers remain convergent at 1,5/3 with medium-low confidence.

Frequently asked questions

What is Generali's defensive profile?

Generali presents a dominant eurozone exposure, accompanied by pan-European diversification through Austria CAVIE/VIG and the CEE zone. Its activity relies largely on long-term euro government bonds, making it a typically defensive case with a stable dividend track record. Eligibility for PEA, with a 15 % withholding instead of 26 %, reinforces its attractiveness for medium-term exposure.

Why is the insurance sector disadvantaged?

The sector is at the tail of the bullish sector ranking and suffers from the BCE rate hike to 2,25 %, i.e. +0,25 pt over six months. This rise weighs on the value of long durations, the main driver of insurance companies. Generali does not appear in any of the four favoured sectors of the brief (semis/AI, electrification, energy, defensive healthcare), which deprives the case of the current sector tailwind.

What is missing to validate the 13,5 % ROE target?

Several fundamental data remain unverifiable: FY 2025 results, S1 2026 results, current PER, Solvency II Tier 1 2026 ratio, Altman M-Score and exposure to Italian BTPs. Without these elements, it is impossible to confirm or refute the achievement of the 13,5 % ROE target set out in the Lifetime Partner 24 plan. The publication of the next half-yearly results would constitute the natural validation catalyst.

What is the role of the BCE meeting on 10/09?

The BCE meeting scheduled for 10/09 represents the main short-term macroeconomic catalyst for the insurance sector. An accommodative decision, with a cut or status quo on key rates, would support the value of long durations and defensive valuations. Conversely, a further hike would worsen the bearish pressure on Generali, already sensitive at the current 2,25 % level.

What does a weak signal with a 3/3 vote mean?

The weak signal reflects limited conviction due to the absence of a major technical catalyst and the lack of live fundamental data. The unanimous 3/3 vote reflects an internal consensus on current caution. The weighted deterministic signal, at -0,50, weighs negatively, while the positive technical verdict alone is not enough without validation of FY 2025 and S1 2026 results. No action is recommended.

Sources

No official filing is attached to this stock in the database to date. The figures quoted above come from an automated arbitration: they have not been re-checked one by one.

Automated AI analysis: limitations and transparency

This content is an automated analysis produced using artificial intelligence. Personal analysis for information purposes — no personalised investment advice. MMR content consists of general research. It does not take account of your financial circumstances, objectives or risk tolerance. Data, analyses and results, including those produced using artificial intelligence, may contain errors, be incomplete or become outdated. No return or outcome is guaranteed. All investments carry a risk of partial or total loss of capital. Past performance and simulations do not predict future results. Before making any decision, check information against original sources and, where necessary, consult an authorised professional. You remain responsible for your investment decisions. This notice does not exclude or limit any liability that cannot legally be excluded or limited.
Tool and analysis: QDNA, Aurélien Ambert.
Analysis (arbitration) completed on September 4, 2026; this page was completed on September 4, 2026 at 13:13 (UTC).
Interests: no position in the stock analysed (G.MI) is recorded in the data consulted on September 12, 2026 (UTC). This does not confirm the absence of holdings or other interests. The situation at the analysis publication date has not been reconstructed.
This declaration covers only recorded positions in this stock; it is not an exhaustive verification of other interests or remuneration.
Methodology: analysis chain, score formula and scale described on the public methodology page.
Analysis horizon: 2035.